The independent source for health policy research, polling, and news.
681 - 700 of 1,568 Results
After a San Francisco speech focused mostly on Medicare, Seema Verma fielded questions that underscored the administration’s differences with California on other key health care issues.
Seniors often don’t realize that private insurers are required to offer Medigap policies, or supplemental insurance, only when people first sign up for Medicare.
The CEO of Comprehensive Pain Specialists was indicted in April. Now the group is closing clinics across several states.
Other states are watching to see if controlling how much hospitals get paid can continue to hold down costs in “Big Sky Country.”
One in 5 Medicare patients who leave the hospital for a nursing home end up back in the hospital. To discourage this, the Centers for Medicare & Medicaid Services will soon give bonuses and penalties to facilities based on their rehospitalization rates.
Use this tool to see how skilled nursing homes in the U.S. performed on two metrics of quality.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Stephanie Armour of The Wall Street Journal and Rebecca Adams of CQ Roll Call discuss how Medicare, Medicaid and the fate of the Affordable Care Act are playing out in the politics of the coming midterm elections. Plus, Rovner interviews Matt Eyles, president and CEO of America’s Health Insurance Plans.
The Medicare board of trustees said the program's hospital insurance trust fund could run out of money by 2026, three years earlier than previously forecast.
Tacking on an after-hours surcharge to an emergency department bill strikes some consumers as unfair, since the facilities are open 24 hours a day.
Sometimes a drug plan’s copayment is higher than the cash price, and under a little-known federal rule, pharmacists have to tell Medicare beneficiaries that — but only if they ask.
The drugmaker agreed to a settlement with the Justice Department over allegations that it funneled copay assistance money through a foundation to Medicare patients.
The Trump administration is shaming brand-name drugmakers who refuse to sell samples so generics can be made from their products.
Even under a decent plan, you’ll have to dig deep in your pocket for crowns, bridges and implants. The mouth isn’t covered by insurance the same way as the rest of the body, and this division has deep roots in history and tradition.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Rebecca Adams of CQ Roll Call discuss President Donald Trump’s proposals to control prescription drug prices and the efforts to sell the plan to lawmakers and the public. Also, Rovner interviews emeritus law professor Timothy Jost about the state of the Affordable Care Act.
As many as 16 million people in the United States have undiagnosed or uncorrected vision problems that could be fixed with eyeglasses, contact lenses or surgery.
President Donald Trump’s much-awaited speech about slashing drug costs was long on rhetoric but short on specifics that will reduce prices.
All private health plans, Medicare, state Medicaid programs and the VA now cover some e-visits — albeit with restrictions.
Federal law prohibits them from using the coupons drugmakers offer to help patients cover their share of a medicine’s cost.
The saga of Martin Shkreli and Turing Pharmaceuticals focused a lot of attention on prescription drug prices, but no reversal of the exponential price increases for the lifesaving drug Daraprim resulted. The story offers an object lesson into the interworkings of the pharmaceutical market.
Newsletter editor Brianna Labuskes, who reads everything on health care to compile our daily Morning Briefing, offers the best and most provocative stories for the weekend.
© 2026 KFF